US Patent 7247297 Use of DF3/MUC1 regulated expression in gene therapy
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Donald W. Kufe0
Ralph R. Weichselbaum0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+381 characters)
Article
Patent abstract
The present invention provides for improved vectors for use in gene therapy. Utilizing the cancer specific DF3/MUC1 promoter to drive a replication essential gene, vectors are made conditionally replication-competent, permitting wider infection and expression of tumor cells. In addition, therapeutic genes and adjunct therapies further increase anti-tumor efficacy.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07247297 Use of DF3/MUC1 regulated expression in gene therapy US Patent 7247297 Use of DF3/MUC1 regulated expression in gene therapy
Infobox
Patent Number
072472970
Patent Number
72472970
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072472970
Date of Patent
July 24, 2007
0Patent Application Number
102447050
Date Filed
September 16, 2002
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07247297 Use of DF3/MUC1 regulated expression in gene therapy
Infobox
Is a
Patent jurisdiction
Patent number
07247297
Date of patent
July 24, 2007
Patent application number
10244705
Date Filed
September 16, 2002
Patent primary examiner
Find more entities like US Patent 7247297 Use of DF3/MUC1 regulated expression in gene therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.